Kenneth Garson
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer.
Journal: Molecular cancer therapeutics
Published: October 09, 2024
NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens.
Journal: Frontiers in immunology
Published: September 15, 2023
PAX2 induces vascular-like structures in normal ovarian cells and ovarian cancer.
Journal: Experimental and therapeutic medicine
Published: September 06, 2021
PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming.
Journal: International journal of oncology
Published: July 26, 2019
Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of Tumors.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 29, 2016
Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: March 24, 2015
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing.
Journal: Nature communications
Published: November 26, 2014
Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm.
Journal: Reproduction (Cambridge, England)
Published: October 11, 2014
Optimization of lentiviral vector production using polyethylenimine-mediated transfection.
Journal: Oncology letters
Published: February 09, 2014
A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population.
Journal: Frontiers in oncology
Published: September 30, 2013
Last Updated: 09/26/2026